SEARCH FINANCIAL SERVICES INFRASTRUCTURE SECURITY SCIENCE INTERVIEWS

 

     

Element AVITI System Debuts

March 14, 2022

Element AVITI System is a benchtop sequencer offering an unrivaled combination of performance, cost, and flexibility. Element’s proprietary Avidity Sequencing chemistries enables exceptional accuracy and cost efficiency that is unmatched by other benchtop systems. The AVITI System operates two random access flow cells that enable independent run start flexibility of each flow cell, and the AVITI operating software features tunable read throughput control for additional run time flexibility.

The launch of the AVITI System is the latest in a series of announcements that have highlighted Element’s key partnerships with established and emerging leaders in the NGS Library Prep and Bioinformatics segments, each of whom demonstrate powerful use cases for the AVITI System. These partners include, in alphabetical order: Agilent Technologies, Dovetail Genomics, Fabric Genomics, Genoox, Google DeepVariant, Jumpcode Genomics, New England Biolabs (NEB), QIAGEN, Roche, Sentieon, 10x Genomics, and Watchmaker Genomics.

“With the launch of our AVITI System, Element is delivering on its vision to dramatically expand access to high quality, low cost, easy-to-use genomics tools,” said Molly He, Ph.D., CEO and Co-Founder of Element Biosciences. “And with the recent Loop Genomics acquisition, we will offer both short and long-read capabilities on a single platform. AVITI will bring the ultimate freedom and flexibility for users.”

“In beta testing both the library compatibility and sequencing performance proved to be as straightforward and impressive as we’d hoped. Users will feel very confident with adopting the AVITI System in terms of both workflow and data quality,” said Shawn Levy, Senior Vice President of Applications and Scientific Affairs, Element Biosciences.

“There is often a sacrifice between accuracy, throughput, and costs. With Element’s new benchtop sequencer, researchers will not be forced to make those compromises. They will receive industry leading quality and cost at a throughput level that more closely matches the needs of most applications,” said John Stuelpnagel, Chairman of Element Biosciences.

Element has released seven application and technology notes along with five sequencing datasets for download that cover human whole genome, bacterial whole genome, and RNA-Seq assays using the Element AVITI System. Access these assets and learn more about AVITI here.

Element is now accepting orders for the AVITI System, with shipments expected to begin in Q2 2022.

Terms of Use | Copyright © 2002 - 2022 CONSTITUENTWORKS SM  CORPORATION. All rights reserved. | Privacy Statement